Collaboration to Understand Complex Diseases: Preeclampsia and Adverse Pregnancy Outcomes

James M Roberts1, Deborah Mascalzoni2, Roberta B Ness2

  • 1From the Departments of Obstetrics, Gynecology, and Reproductive Sciences, Epidemiology and Clinical and Translational Research, Magee-Womens Research Institute, University of Pittsburgh, PA (J.M.R.); Centre for Research Ethics and Bioethics, Department of Public Health, Uppsala University, Uppsala, Sweden (D.M.); Centre for Biomedicine EURAC, Bolzano, Italy (D.M.); University of Texas School of Public Health, Houston (R.B.N.); and Division of Women's Health, Women's Health Academic Centre, King's College London, London, United Kingdom (L.P.). jroberts@mwri.magee.edu.

Abstract

No abstract available in PubMed .

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76